1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Imports
  5. Import of Antisera and O…

Import of antisera and other blood fractions to Jordan goes down in 2016

Compared to the previous year the indicator fell by 25.69 percent, new numbers from United Nations Statistical Office demonstrate. The variable declined by 13 981 kilogram, in comparison to the prior year when it grew by 28.21%. Jordan saw a rise of 78.49% in pharmaceutical import during the last 23 years. Though, it has shown a negative compound average annual growth rate of 0.04% during the 5 years with a modest overall raise since the start of time series. It averaged 28 717.39 kilogram from 1994 to 2016 and it hit its all-time high of 54 417 kilogram in 2015 and record low of 14 575 kilogram in 2005.

Import of antisera and other blood fractions to Jordan goes down in 2016
Date Kilogram Variation
2016 40 436.00 -25.69
2015 54 417.00 28.21
2014 42 442.00 22.23
2013 34 724.00 -29.23
2012 49 066.00 7.3
2011 45 727.00 10.72
2010 41 298.00 24.46
2008 33 183.00 34.72
2007 24 631.00 -5.65
2006 26 106.00 79.11

Related Statistics

Pharmaceutical Imports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales